CollPlant

114 articles about CollPlant

• CollPlant Appoints David Tsur as Chairman of the Board

  1/16/2018

  CollPlant announced the appointment of David Tsur to the position of Chairman of the Board of Directors, effective immediately.

• CollPlant Receives Substantial, Repeat Order for its Biological Ink

  11/29/2017

  CollPlant announced that it has received an additional order, totaling hundreds of thousands of dollars, for the supply of its collagen and biological ink.

• CollPlant Expands European Sales Network: The Company Has Signed a Distribution Agreement in Greece and Cyprus for Vergenix FG for Treatment of Acute and Chronic Wounds and Surgical Cuts

  11/28/2017

  Under the terms of the agreement, the distributor undertook to make the first order for the product when signing the agreement, in an amount that is not material to the Company.

• Vote of Confidence in CollPlant: Completion of Agreement for Immediate Investment of USD 1.1 Million From Ami Sagi, One of the Company's Largest Shareholders

  11/13/2017

  CollPlant announces that it has signed a private restricted investment agreement with Mr. Ami Sagi, one of the Company's largest shareholders.

• CollPlant Signs Definitive Agreement For $5 Million Private Placement With U.S. Investor

  9/11/2017

• CollPlant In Advanced Negotiations For US Private Placement Of USD 5.0 Million; Agreement Includes Plan For NASDAQ Uplisting

  9/5/2017

• CollPlant Files Patent For 3D Bio-Printing Of Organs And Tissues

  6/12/2017

• CollPlant Provides Operational Update For Q1 2017

  5/31/2017

• CollPlant Extends its European Distribution Network With Signing Of New Distribution Agreement In Turkey For VergenixFG Wound Treatment

  5/22/2017

• CollPlant's New Division Focuses on 3D Bio-Printing of Organs and Tissues

  5/12/2017

• CollPlant Reports Positive Results From Post-Marketing Surveillance of Vergenix FG

  4/11/2017

• CollPlant Provides Commercial And Operational Update

  3/31/2017

• CollPlant Signs Exclusive Distribution Agreement With Arthrex For Vergenix™STR

  11/9/2016

• CollPlant Files Paperwork for $25 Million IPO

  10/26/2016

• CollPlant Receives CE Mark For VergenixSTR For Treatment Of Tendinopathy

  10/19/2016

• CollPlant Reports Positive Final Extended Clinical Trial Results With Vergenix STR For Treatment Of Tendinopathy

  8/18/2016

• CollPlant Receives Chief Scientist's Authorization For A NIS 12 Million Research And Development Projects With Funding Of Approximately 50%

  5/31/2016

• CollPlant Receives CE Mark for Vergenix FG Wound Filler

  2/23/2016

• CollPlant Reports Positive Final Trial Results For Vergenix STR, Indicated For The Treatment Of Tendinopathy

  2/4/2016

• CollPlant Reports Positive Interim Trial Results For VergenixSTR, Indicated For The Treatment Of Tendinopathy

  12/8/2015